Ricks v. Khan

135 F.4th 296
CourtCourt of Appeals for the Fifth Circuit
DecidedApril 25, 2025
Docket20-20303
StatusPublished
Cited by3 cases

This text of 135 F.4th 296 (Ricks v. Khan) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ricks v. Khan, 135 F.4th 296 (5th Cir. 2025).

Opinion

Case: 20-20303 Document: 119-1 Page: 1 Date Filed: 04/25/2025

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit ____________ FILED No. 20-20303 April 25, 2025 ____________ Lyle W. Cayce Clerk Mark Eugene Ricks,

Plaintiff—Appellant,

versus

Jessica Khan, MD; Jamie Williams; Monica Pickthall; John Doe, UTMB Doctor; John Doe, UTMB Doctor; John Doe, UTMB Policy Maker; Jane Doe, UTMB Policy Maker,

Defendants—Appellees. ______________________________

Appeal from the United States District Court for the Southern District of Texas USDC No. 4:19-CV-587 ______________________________

Before King, Richman, and Higginson, Circuit Judges. Priscilla Richman, Circuit Judge: Mark Eugene Ricks was incarcerated by the Texas Department of Criminal Justice (TDCJ). Proceeding in forma pauperis (IFP) and pro se, Ricks filed suit under 42 U.S.C. § 1983 against employees of the University of Texas Medical Branch (UTMB), which provides TDCJ with healthcare services. Ricks alleges that the defendants violated his right to be free from cruel and unusual punishment under the Eighth Amendment in two ways. First, he asserts that he was denied treatment for chronic hepatitis C virus Case: 20-20303 Document: 119-1 Page: 2 Date Filed: 04/25/2025

No. 20-20303

(HCV) based solely on nonmedical reasons. Second, he alleges that the TDCJ HCV Policy (Policy) was the moving force behind that unconstitutional denial of treatment. The district court granted the defendants’ motion to dismiss, holding that Ricks’s allegations failed to state a claim for deliberate indifference. The district court also denied Ricks’s motion for appointment of counsel. Ricks appeals both decisions. We vacate the district court’s orders granting the motion to dismiss and denying appointment of counsel, and we remand with instructions that Ricks be given leave to amend his pleadings and that counsel be appointed to represent Ricks. I Ricks is a Texas state prisoner who has chronic HCV. Ricks filed suit under 42 U.S.C. § 1983 against Jamie Williams, a medical practice manager; Monica Pickthall, a physician’s assistant in the HCV clinic; Dr. Jessica Khan; and Doe Defendants. He alleges that (1) Williams, Pickthall, and the Doe Defendants violated his Eighth Amendment rights by inadequately treating his HCV, and (2) Dr. Khan and the Doe Defendants implemented an unconstitutional HCV policy. In reviewing a motion to dismiss for failure to state a claim, we accept the complaint’s allegations as true. 1 The following facts are based on Ricks’s complaint and attachments to it, including several publications and articles. HCV attacks the liver, and some individuals affected by it develop chronic HCV. If left untreated, chronic HCV can cause scarring, disease, and cancer of the liver. “HCV-associated liver disease is a frequent cause of death in inmates . . . .” Before 2011, HCV was treated with interferon, but by 2013, direct acting antiviral (DAA) drugs were introduced to treat the _____________________ 1 Norsworthy v. Hous. Indep. Sch. Dist., 70 F.4th 332, 336 (5th Cir. 2023).

2 Case: 20-20303 Document: 119-1 Page: 3 Date Filed: 04/25/2025

disease. DAAs have few adverse side effects and yield “sustained virological response . . . rates in excess of 95% for most HCV patient populations.” Guidance published by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America on March 11, 2019, “recommend[s] [DAA] treatment for all patients with chronic HCV infection, except those with a short life expectancy that cannot be remediated by HCV [DAA] treatment, liver transplantation, or another directed therapy.” Ricks contracted HCV in the Dallas County Jail. In 2011, TDCJ treated Ricks with an interferon treatment. It was unsuccessful. Ricks alleges that he requested DAA treatment multiple times after the interferon treatment failed. In 2015, Ricks was referred to Pickthall, who he alleges “ordered that ultrasounds be taken every six months.” After requesting a copy of one of his ultrasounds in December 2016, Ricks learned that his “liver had worsened to the point where it was ‘morphing’ to [cirrhosis].” Ricks’s ultrasounds confirm the cirrhosis determination, and his relevant lab test results indicate severe liver scarring in 2013 and cirrhosis in 2017. In February 2017, Ricks filed a grievance requesting he receive DAAs in order to prevent his illness from progressing. Ricks alleged that he was being denied DAA treatment under the Policy because he was “not sick enough.” In response to this grievance, Williams advised that Ricks was not eligible for treatment under the Policy and that treatment would not “be denied [to Ricks] if deemed medically necessary.” The response did not explain the criteria for eligibility or for deeming treatment medically necessary. In response to a subsequent grievance, Ricks was advised that he was ineligible for DAAs because his enzyme levels exceeded the limitation for initiation of treatment, and he was being treated in accordance with the Policy.

3 Case: 20-20303 Document: 119-1 Page: 4 Date Filed: 04/25/2025

In February 2019, Ricks brought suit under 42 U.S.C. § 1983, seeking injunctive and declaratory relief as well as damages. After Ricks filed suit, he was approved for treatment and started receiving DAAs in April 2019. Ricks’s complaint and more definite statement alleged that the UTMB officials were deliberately indifferent to his serious medical needs in violation of his Eighth Amendment right to be free from cruel and unusual punishment because they failed either to treat his HCV or “to enact [a] policy protecting patients from progressing to [cirrhosis].” The district court allowed Ricks to proceed IFP but declined to appoint counsel. The defendants filed a motion to dismiss Ricks’s claims under Federal Rule of Civil Procedure 12(b)(1) as moot and under Rule 12(b)(6) for failure to state a claim upon which relief could be granted. The district court granted the motion and dismissed Ricks’s complaint with prejudice for failure to state a claim. Ricks filed a timely Rule 59(e) motion for reconsideration, which the district court denied. Ricks filed a timely notice of appeal. 2 The district court denied Ricks leave to proceed IFP and certified pursuant to 28 U.S.C. § 1915(a)(3) and Federal Rule of Appellate Procedure 24(a)(3)(A) that any appeal would not be taken in good faith. Ricks filed motions in this court for leave to proceed IFP and for appointment of counsel, which we granted. II We review de novo a district court’s grant of a motion to dismiss for failure to state a claim under Rule 12(b)(6). 3 “To avoid dismissal for failure

_____________________ 2 See Fed. R. App. P. 4(a)(1)(A), (a)(4)(A)(iv). 3 Whitaker v. Collier, 862 F.3d 490, 496-97 (5th Cir. 2017) (“A dismissal for failure to state a claim under Rule 12(b)(6) is reviewed ‘de novo, accepting all well-pleaded facts as true and viewing those facts in the light most favorable to the plaintiff.’” (alteration in original) (italics omitted) (quoting Bowlby v. City of Aberdeen, 681 F.3d 215, 219 (5th Cir. 2012))).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
135 F.4th 296, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ricks-v-khan-ca5-2025.